Regenerative Medicine Market
12-Sep-2018 | Number of pages: 175 | Report Id: BMRC PH 132 | Report Format: | Status: Published

Regenerative Medicine Market By Product Type (Cell-based products, Acellular products), By Application (Orthopedic & Musculoskeletal Disorders Cardiology, Dermatology, Diabetes, Central Nervous System Disorders), By Therapy (Cell therapy, Gene therapy, Tissue engineering, Immunotherapy), Industry Analysis, Trends, and Forecast 2018 – 2024


Regenerative Medicine MarketIncreased in bone and joint surgeries and increased prevalence of neurodegenerative, orthopedic, oncology, and genetic diseases are the key drivers for Global Regenerative Medicine Market.

Regenerative Medicine Market is valued at around USD 16148.16 Million in 2017 and expected to reach USD 74831.35 Million by 2024 with the CAGR of 22.27% over the forecast period.

Regenerative Medicine market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about regenerative medicine market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with of Product Type, application, therapy.

Regenerative medicines are those medicines which are used to repair, regenerate, and replace the tissues or organs damaged due to disease, injury or natural aging. Regenerative medicines are used in the treatment of various disorders such as orthopedic, neurodegenerative, oncology and others. These medicines help in the restoration of natural functioning of the organs and tissues. Regenerative medicines can also be used for the treatment of various chronic and genetic disorders, it also helps in the treatment of organ transplant which has reduced the rejection cases to a major extent.

Regenerative Medicine Market

There are various factors driving the growth of the regenerative medicine market, one of the major driving the growth of the market are increased prevalence of various chronic and genetic diseases over the period of time. Moreover, increase in technological advancement has also help in the development of effective and better therapies for the treatment of chronic disorders. Furthermore, the increased burden of these diseases has increased the demand of various effective medications which led to the increase in the regenerative medicine market. Increased research on stem cells has given a new direction to the regenerative medicines an expected to create various opportunities over the forecast period. However, high cost of treatment and stringent government regulations are expected to inhibit the growth of regenerative medicines over the forecast period.

Global regenerative medicines market report covers prominent players like Stryker Corporation, Cook Biotech Inc., Vericel Corporation, DePuy Synthes, Inc. Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, Inc., NuVasive, Inc., Acelity (KCI Concepts), Zimmer Holdings, Inc., Integra LifeSciences, C.R. Bard and others.

Regenerative Medicine Market

Regenerative Medicine Market Revenue (USD Million) Analysis, 2018-2024

Regenerative Medicine Market Segmentation

By Product Type

  • Cell-based products
  • Acellular products

By Application

  • Orthopedic & Musculoskeletal Disorders
  • Cardiology
  • Dermatology
  • Diabetes
  • Central Nervous System Disorders
  • Others

By Therapy

  • Cell therapy
  • Gene therapy
  • Tissue engineering
  • Immunotherapy

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Regenerative Medicine Market Key Players

  • Stryker Corporation
  • Cook Biotech Inc.
  • Vericel Corporation
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • NuVasive, Inc.
  • Zimmer Holdings, Inc.
  • Integra LifeSciences
  • Others


Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Regenerative Medicine Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Regenerative Medicine Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Regenerative Medicine Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Regenerative Medicine Market Overview: Quantitative Analysis
    • Global Regenerative Medicine Market Consumption, Market Share ( %) and Growth Rate, 2014- 2024
    • Global Regenerative Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter – Global Regenerative Medicine Market Analysis: by Product Type
  3. Chapter – Global Regenerative Medicine Market Analysis: by Application
  4. Chapter – Global Regenerative Medicine Market Analysis: by Therapy
  5. Chapter – Global Regenerative Medicine Market Analysis: by Manufacturer
    • Global Regenerative Medicine Market Revenue (USD Million), by Manufacturer, 2014 – 2024
    • Global Regenerative Medicine Market Consumption, Manufacturer, 2014 – 2024
    • Global Regenerative Medicine Market Share (%), by Manufacturer, 2017
    • Global Regenerative Medicine Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Regenerative Medicine Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  6. Chapter – Regenerative Medicine Market: Regional Analysis
    • North America
      • North America Regenerative Medicine Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
      • North America Regenerative Medicine Market Revenue (USD Million) By Country, 2014 – 2024.
      • North America Regenerative Medicine Revenue Market Share (%) By Country, 2014 – 2024.
      • North America Regenerative Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
      • North America Regenerative Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
      • North America Regenerative Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  7. Chapter – Company Profiles
    • R. Bard
      • Overview
      • Financials
      • Product portfolio
      • Regenerative Medicine Market Revenue (USD Million), Consumption  and Market Share (%), 2014 – 2017
      • Regenerative Medicine Sales Market Share (%), 2014 – 2017
      • Business strategy
      • Recent developments
    • Stryker Corporation
    • Cook Biotech Inc.
    • Vericel Corporation
    • DePuy Synthes, Inc.
    • Medtronic, Inc.
    • Organogenesis Inc.
    • Osiris Therapeutics, Inc.
    • NuVasive, Inc.
    • Zimmer Holdings, Inc.
    • Integra LifeSciences
    • Others
  8. Chapter – Market Research and Findings








TAGS: Regenerative MedicineRegenerative Medicine Market GrowthRegenerative Medicine Market Trends